Literature DB >> 10722561

Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.

S Ajdary1, M H Alimohammadian, M B Eslami, K Kemp, A Kharazmi.   

Abstract

Th1-type cellular immune responses play a critical role in protection against infection with Leishmania parasites, whereas activation of Th2-type cells results in progressive disease. Cutaneous leishmaniasis caused by Leishmania major is often a self-healing disease; however, persistent nonhealing forms are also known. In the present study, we have described cell-mediated immune responses in nonhealing patients by measuring T-cell proliferation, cytokine production, and phenotypic characterization of these cells. The responses were compared with those of patients with active lesions, patients who had recovered from infection, and healthy controls. Peripheral blood mononuclear cells from patients with active lesions and recovered donors proliferated vigorously and produced Th1-type cytokine when stimulated with L. major antigens, whereas in nonhealing patients the proliferative responses were significantly lower and showed a Th2-type response to Leishmania antigens. Interleukin-10 (IL-10) production was not a feature of L. major stimulation. Flow cytometric analysis revealed that L. major antigen induced proliferation of the CD4-positive population and that these cells were the major source of gamma interferon and IL-4. These results show a distinct dichotomy in the cytokine response to L. major infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722561      PMCID: PMC97345          DOI: 10.1128/IAI.68.4.1760-1764.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  The role of IL-10 in crossregulation of TH1 and TH2 responses.

Authors:  T R Mosmann; K W Moore
Journal:  Immunol Today       Date:  1991-03

2.  Studies on cutaneous leishmaniasis in Khuzestan, Iran. Part I. The leptomonad infection of sandflies.

Authors:  E Javadian; A Mesghali
Journal:  Bull Soc Pathol Exot Filiales       Date:  1974 Sep-Oct

3.  Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis.

Authors:  K Kemp; T G Theander; L Hviid; A Garfar; A Kharazmi; M Kemp
Journal:  Scand J Immunol       Date:  1999-06       Impact factor: 3.487

4.  Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

Authors:  H W Ghalib; M R Piuvezam; Y A Skeiky; M Siddig; F A Hashim; A M el-Hassan; D M Russo; S G Reed
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Cytokine patterns in the pathogenesis of human leishmaniasis.

Authors:  C Pirmez; M Yamamura; K Uyemura; M Paes-Oliveira; F Conceição-Silva; R L Modlin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 6.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

7.  Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.

Authors:  P Scott; E Pearce; P Natovitz; A Sher
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

8.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

9.  In situ characterization of the cutaneous immune response in Ethiopian cutaneous leishmaniasis.

Authors:  R Nilsen; R N Mshana
Journal:  Scand J Immunol       Date:  1987-11       Impact factor: 3.487

10.  IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.

Authors:  P Scott
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

View more
  40 in total

1.  Childhood cutaneous leishmaniasis: report of 117 cases from Iran.

Authors:  Safar Ali Talari; Rezvan Talaei; Gholamreza Shajari; Zarichehr Vakili; Abbas Taghaviardakani
Journal:  Korean J Parasitol       Date:  2006-12       Impact factor: 1.341

2.  Comparison of Th1 and Th2 responses in non-healing and healing patients with cutaneous leishmaniasis.

Authors:  Maryam Shahi; Masoud Mohajery; Seyyed Ali Akbar Shamsian; Hossein Nahrevanian; Seyyed Mohammad Javad Yazdanpanah
Journal:  Rep Biochem Mol Biol       Date:  2013-04

3.  Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis.

Authors:  Mohammad H Alimohammadian; Stephen L Jones; Haideh Darabi; Farhad Riazirad; Soheila Ajdary; Aliakbar Shabani; Mohammad A Rezaee; Mehdi Mohebali; Zohreh Hosseini; Farrokh Modabber
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

4.  Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.

Authors:  Tiago M Castilho; Karen Goldsmith-Pestana; Caterin Lozano; Liliana Valderrama; Nancy G Saravia; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

5.  T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.

Authors:  Alda Maria Da-Cruz; Rita Bittar; Marise Mattos; Manuel P Oliveira-Neto; Ricardo Nogueira; Vanessa Pinho-Ribeiro; Rilza Beatriz Azeredo-Coutinho; Sergio G Coutinho
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis.

Authors:  Manuel Modolell; Beak-San Choi; Robert O Ryan; Maggie Hancock; Richard G Titus; Tamrat Abebe; Asrat Hailu; Ingrid Müller; Matthew E Rogers; Charles R M Bangham; Markus Munder; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

7.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

8.  CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.

Authors:  Mahmoud Nateghi Rostami; Hossein Keshavarz; Rosita Edalat; Abdolfattah Sarrafnejad; Tahereh Shahrestani; Fereidoun Mahboudi; Ali Khamesipour
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

9.  CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis.

Authors:  R Jafari-Shakib; S Ajdary; Z Mohtasham Amiri; A M Mohammadi; K Nourijelyani; H Mortazavi; M A Shokrgozar; B Nikbin; A Khamesipour
Journal:  Clin Exp Immunol       Date:  2008-05-05       Impact factor: 4.330

Review 10.  Present status of antileishmanial vaccines.

Authors:  Monidipa Ghosh; Santu Bandyopadhyay
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.